{"id":"W4416017497","doi":"10.1016/j.lungcan.2025.108834","title":"MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Durvalumab; Chemotherapy; Lung cancer; Disease; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007105106,0.0004045272,0.001557204,0.0002190158,0.0002713387,0.000666798,0.0006742603,0.0006220524,0.002487641],"category_scores_gemma":[0.0007946289,0.0001821443,0.00093145,0.0002500918,0.0004894673,0.0006991356,0.0002347579,0.001835627,0.0003111446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001462164,"about_ca_system_score_gemma":0.001018309,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002593033,"about_ca_topic_score_gemma":0.01001072,"domain_scores_codex":[0.9997035,0.00008753927,0.00002087044,0.00005952106,0.00002607091,0.0001024646],"domain_scores_gemma":[0.9997024,0.00008131057,0.00003914573,0.0000243711,0.00001001478,0.0001428013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7364213,0.006905856,0.008593152,0.0006446441,0.001560263,0.0006620545,0.000195947,0.00398394,0.01300133,0.0008083921,0.004981427,0.2222416],"study_design_scores_gemma":[0.3330016,0.4345528,0.1576428,0.0004563145,0.005846803,0.003339166,0.0006016255,0.01651647,0.01646657,0.003091456,0.02825945,0.0002249564],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.99097,0.00502533,0.0001665428,0.0006013663,0.0002489507,0.0001412962,0.0003862771,0.00004115139,0.002418954],"genre_scores_gemma":[0.9970654,0.001148968,0.0002608769,0.0002849159,0.00006462196,0.00008653437,0.0003036514,0.000006879198,0.0007780577],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002593033,"threshold_uncertainty_score":0.01060879,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009759950064900491,"score_gpt":0.3044476110311205,"score_spread":0.29468766096622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}